Spots Global Cancer Trial Database for advanced cancer of the breast
Every month we try and update this database with for advanced cancer of the breast cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of ARV-471 (PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer | NCT05909397 | Breast Cancer | ARV-471 (PF-078... Palbociclib Letrozole Palbociclib | 18 Years - | Pfizer | |
A Study of ARV-471 (PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer | NCT05909397 | Breast Cancer | ARV-471 (PF-078... Palbociclib Letrozole Palbociclib | 18 Years - | Pfizer |